Compare APGE & PBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APGE | PBF |
|---|---|---|
| Founded | 2022 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 5.7B |
| IPO Year | 2023 | 2011 |
| Metric | APGE | PBF |
|---|---|---|
| Price | $134.08 | $64.33 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 12 |
| Target Price | ★ $109.67 | $36.25 |
| AVG Volume (30 Days) | ★ 5.4M | 2.7M |
| Earning Date | 05-12-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.55% |
| EPS Growth | N/A | ★ 69.78 |
| EPS | N/A | ★ 1.65 |
| Revenue | N/A | ★ $24,508,200,000.00 |
| Revenue This Year | N/A | $8.77 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $39.98 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $34.34 | $21.24 |
| 52 Week High | $134.35 | $66.05 |
| Indicator | APGE | PBF |
|---|---|---|
| Relative Strength Index (RSI) | 80.75 | 76.10 |
| Support Level | $80.52 | $36.97 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.43 | 2.89 |
| MACD | -1.69 | 1.21 |
| Stochastic Oscillator | 86.53 | 82.37 |
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
PBF Energy Inc is an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants, and other petroleum products in the United States. The company owns refineries in Delaware, Ohio, New Jersey, California, and Louisiana. The Company operates in two reportable business segments: Refining and Logistics. The Company's oil refineries are all engaged in the refining of crude oil and other feedstocks into petroleum products and are aggregated into the Refining segment. PBFX operates logistics assets such as crude oil and refined products terminals, pipelines, and storage facilities. The Logistics segment consists solely of PBFX's operations.